We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Advanced Medical Solutions Group Plc | LSE:AMS | London | Ordinary Share | GB0004536594 | ORD 5P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
5.00 | 2.44% | 209.50 | 208.50 | 210.00 | 211.00 | 200.00 | 200.00 | 538,938 | 16:35:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Plastics,resins,elastomers | 126.21M | 15.89M | 0.0730 | 28.56 | 445.3M |
Date | Subject | Author | Discuss |
---|---|---|---|
02/12/2020 18:26 | Not a high profile sector, I guess. Always thought of them as a takeover target, but not in these Covid-obsessed times. | wetdream | |
01/12/2020 22:15 | Really nice jump Not even sure if anyone cares anymore. | whitebicycle | |
24/11/2020 07:52 | Looks like the news caused some trading algorithms to go into meltdown! Dozens of single share trades before 8.30am. Weird. | wetdream | |
23/11/2020 16:32 | The market loved todays acquisition news by AMS. | dealit | |
23/11/2020 16:31 | Advanced Medical Solutions acquires Raleigh Adhesive Coatings, reports Investor's Champion. For the 6 months ending 31 October Raleigh generated revenue of £3.9m and operating profit of £0.8m, compared to the prior year’s loss of £0.3m. The £22m acquisition cost therefore represents quite a multiple, suggesting AMS thinks highly of this business. | energeticbacker | |
20/11/2020 21:33 | Bigger Holders are Key here Covid-19 developments likewise ref continuance of elective surgeries in the USA , EU , UK and other sales areas If mid 2021 is when vaccines will start to be used in any meaningful quantity , then that is over 7 months away and Covid-19 cases look set to go on rising till then in the absence of National Lockdowns of decent duration to do any good eg 8 weeks buywell is of the opinion that more pandemics are coming and Covid-19 is mutating now via other animal species like Mink which is imo of a major concern or should be to Governments. A DIFFERENT Hospital Care system is now needed for the treatment of virus pandemics Completely separate from existing Hospitals that should be able to carry on as normal as possible New Pandemic/Viral Hospitals equipped specifically to deal with the tools staff and safety requirements that Covid-19 experience has given BUT able to perform as an adjunct to the NHS in the UK for example in none pandemic times If that happens | buywell3 | |
20/11/2020 20:10 | Someone selling the news - c.800k But share price seems pretty solid. | wetdream | |
20/11/2020 18:27 | Agreed. Also a good time for a larger rival to snap it up on the cheap, but don’t tell them | dozey3 | |
20/11/2020 16:49 | AMS received CE mark approval for its Silicone PHMB Foam Dressing, which sits alongside the previously US approval for this product. AMS has had a tough time over the pandemic which has led to the deferral of elective surgeries and woundcare clinics, however, according to Investor's Champion this innovative business remains in good shape and should continue to thrive when markets recover. | energeticbacker | |
16/9/2020 07:35 | Results out today, still making a profit and paying a dividend. Very creditable performance considering Covid 19 times we are going through IMHO. | dealit | |
29/8/2020 06:32 | Always rumoured to be a bid target, Perhaps the sp’s finally reached the floor? | wetdream | |
26/8/2020 07:59 | Something's lit a firework under it. Couldn't find anything apart from the IC article ... | pedr01 | |
21/8/2020 07:33 | Was their an article in the Investors Chronicle, if so did anyone read the article? | dealit | |
10/8/2020 16:28 | Maybe a chance to top up at this s/p. | dealit | |
07/8/2020 14:52 | Sorry that is P/E of 16.4 (typo) | potty punter | |
07/8/2020 14:51 | Well if you take the cash in hand out of the market cap, you get a P/P of 16.4 at present. That is fairly cheap for the sector | potty punter | |
06/8/2020 21:41 | buywell dons the DA hat once more Thus far my last post comments are playing out -- all that remains is for a P/E of 15 to get hit. Will it ? For that to happen Covid-19 cases will have to impinge on planned operations again as it did in the first wave. Will it ? Look at the stats and charts on worldometer website and decide yourself IMO dyor | buywell3 | |
06/8/2020 19:37 | 'ma long term holder who has held thougha nd re-invested dividends I see no reason to sell as this is not, in my opinion, more than a temporary setback- I could change my mind, of course, as events unfold, but it's a strong hold for me No forced seller here | malcontent | |
06/8/2020 12:34 | Alliance Pharma (APH) looks even better value. Medicines will not go out of fashion and are unlikely to suffer long term economic disruption from Covid-19. Chairman and wife bought substantial amountsAPH shares at 77.7p in June, the shares were cheap enough then, even cheaper now at around 70p! AMS'downward trend may have a bit further to go. A sound Company with loads of cash in the bank. Share price Will come up again, depending on next Results showing improved sales. | winnings1 | |
04/8/2020 06:44 | That's better than a kick up the backside. "The UK patent box scheme that is expected to reduce the effective tax rate for the Group by between 1% and 2% throughout the patent life.!" | pedr01 | |
04/8/2020 06:37 | Let us hope this announcement as a positive effect on the s/p:- Winsford, UK: Advanced Medical Solutions Group plc (AIM: AMS), the surgical and advanced wound care specialist company, today announces that it has been granted UK and US patents for the LiquiBand® Exceed range, providing protection until 2034. The design of the applicator, tip and the raw materials used to manufacture the device has allowed it to be distinguished as a novel, patentable technology. These patents provide long-term protection on a core growth driver for the global LiquiBand® portfolio, covering 30-35% of the current product range. In addition, the UK patent will provide an additional tax benefit to the Group via the UK patent box scheme that is expected to reduce the effective tax rate for the Group by between 1% and 2% throughout the patent life. Chris Meredith, Chief Executive Officer of AMS, commented: "With end sales demand for LiquiBand® in the US showing early signs of recovery demonstrated by market share gains in the first quarter of 2020, these newly granted patents will further strengthen and protect growth in our core markets. They also highlight AMS's continued ability to design, develop and sell innovative, patentable technology." | dealit | |
29/7/2020 00:50 | Charts are very useful guides IMO buywell3 13 May '20 - 01:06 - 3168 of 3181 Edit P/E shows at 24.91 above this IMO is too punchy in the current climate A P/E of say 15 would be more in order hence the chart support looks like being tested within weeks IMO dyor | buywell3 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions